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Non-Technical Summary 
 
Hypertension is often asymptomatic, so many people who have clinically serious 
hypertension do not know they have it. We investigate in this paper whether being told their 
exact blood pressure readings and their hypertension status leads to people changing their 
health-related behaviours. Using longitudinal individual data, we track individuals over time to 
test whether any change in behaviours is large enough to show up in the chances of dying from a 
hypertension-related cause such as cardiovascular disease.  
 The identification challenge is to separate underlying individual risks and behavioural 
tendencies from the effects of receiving clinical information. To address this we leverage a 
particular feature of the UK Longitudinal Household Survey (UKLHS) data that produced 
idiosyncratic variation in the clinical information that individuals had regarding their blood 
pressure status (i.e. information that was independent of their own traits and tendencies). The 
survey included a nurse visit during which clinical biomarkers were collected and delivered to 
survey participants and the variation is a result of the phasing of nurse visits across individuals 
over time.  
 Our research yields five important new findings. First, the overall prevalence of 
hypertension in the population is calculated to be 35.0 percent. It is highest amongst those aged 
50 and over (54 percent), with above median income (42.7 percent), without a degree level 
education (38.3 percent), and male (36.5 percent). 9.5 percent of the population received a 
negative hypertension shock from the survey nurse, that is, they have high blood-pressure but 
did not know it. The share receiving a negative shock is highest among African and black 
Caribbean (13.1 percent), those aged 50 and over (12.7 percent), males (11.6 percent), those with 
above median income (10.6 percent) and those without a degree (9.8 percent). 
 Second, providing individuals with a personalised blood pressure warning led 
respondents to revise downwards their perceptions of their own physical health. It also triggered 
more formal diagnosis of hypertension by a GP. Compared to similar people who did not get the 
nurse feedback, the gap in clinically diagnosed hypertension persisted for a substantial four years 
after feedback.  
 Third, the sustained monitoring and advice that follows from visiting a GP in the UK led 
to large reductions in smoking, and some weaker evidence of improvements in diet, but no 
change in exercise behaviours. Future research, ideally using experimental data, may want to 
explore whether different types of feedback could influence diet and exercise. One possibility is 
personalised real time feedback from activity monitors. 
 Fourth, the combined effects of GP monitoring and behavioural improvements appear 
to have been large enough to improve respondent health. We find evidence of lower rates of 
coronary heart disease and congestive heart failure, although no statistical difference in the 
prevalence of strokes. It would be interesting to see if these findings are replicated in other 
studies. 
 Fifth, our work provides methodological insight. Some previous studies in this area have 
used a regression discontinuity design (RDD), comparing people just above the BP threshold 
that leads to a hypertension diagnosis with people just below on the premise that these people 
will tend to be similar. Our examination of the BP data lead us to believe that RDD designs of 
this sort will be vulnerable to the fact that BP measurements vary with temperature, time of day, 
and recent activity. In other words, measures may be too noisy to sustain comparison of people 
with slightly different measurements.  
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Abstract
In this paper we examine the impact of a tailored health warning on health
outcomes. We exploit the design of a household panel survey that provided feedback
to participants on their blood-pressure levels as a quasi-experiment. We find that
many participants who were told their blood-pressure was high went on to get a
formal diagnosis of hypertension from a medical practitioner. The effect of getting a
formal hypertension diagnosis was to reduce the incidence of smoking and improve
the quality of diets. However, we do not find changes in monthly alcohol spending.
The behavioural changes (plus any prescribed medications) were large enough to
reduce the incidence of cardiovascular disease.
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1 Introduction
There is evidence that people do not recognize the existence or severity of chronic disease
conditions, many of which are asymptomatic eg. hypertension, diabetes, cancers. A key
question is whether they would change their behaviours if better informed. This is impor-
tant because, if they did, we may expect behavioural responses to control the condition
and mitigate its impact on their lives, with direct implications for their welfare and posi-
tive externalities for health care services. In particular, even simple pieces of personalised
information might lead to large behavioural changes where the initial information trig-
gers the use of available healthcare services such as advice services or GP monitoring. On
the other hand, if information was ineffective at improving behaviours, this would have
important consequences for our understanding of health behaviours too and the types of
information interventions that might be effective.
In general, it is difficult to identify variation in the health status of individuals or in
their knowledge of their status that is independent of their characteristics. For instance,
individuals from poorer socioeconomic backgrounds may be more likely to have a chronic
disease condition and also less likely to know they have it. Likewise, recommended health
behaviours are more commonly undertaken by individuals with higher socioeconomic sta-
tus and better health (Oster (2019)). If we were designing a study, we would conduct
clinical tests on a representative sample of individuals and then randomize feedback on
their test results to half of them, but this would be expensive and raise ethical issues.
Indeed, recent US trials that aggressively targeted blood pressure (BP) reduction were
stopped early after a median follow-up of 3.26 years owing to a significantly lower rate of
the composite outcome (myocardial infarction, other acute coronary syndromes, stroke,
heart failure, or death from cardiovascular causes) in an intensive-treatment group than
in a standard-treatment group (SPRINT Research Group (2015)). Against this backdrop,
we test the extent to which individual-specific information on health status results in be-
haviour change and then a change in health outcomes up to five years after the original
intervention using a quasi-experiment.
We focus upon a specific hypertension (HT) intervention that took place within a UK
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household panel survey. The intervention warned panel participants when their BP was
high and, if so, advised them to visit their GP for a formal assessment. Usually, if HT
was confirmed by a GP, it would lead to sustained monitoring, that could involve the use
of medications and would certainly include an assessment of lifestyle changes that could
help control BP. We follow the panel participants for up to five years after the initial BP
warning allowing us to study persistence of effects and medium term effects on health
behaviours and outcomes of receiving a formal GP diagnosis of HT.
HT is a chronic condition and a global public health issue. In the US alone a third of
the population had HT and the economic cost to the nation was estimated to be $51.2
billion per year in 2012 (Benjamin et al. (2017)). Being overweight is closely linked to
high BP, as is a lack of physical activity and an unhealthy lifestyle, it can lead to diabetes,
heart disease, stroke and numerous other health problems and in 2010 in the US it counted
for more cardiovascular disease (CVD) deaths than any other modifiable CVD risk factor
(Whelton et al. (2018)). Fortunately, HT can be controlled with medication and lifestyle
choices including changes to diet, exercise, alcohol consumption, weight, and smoking (see,
for example, Maryon-Davis (2005)). Psychological stress can also affect a person’s risk
of high BP and an inverse relationship (cross-country) between measures of pyschological
well-being and BP has been documented (Blanchflower and Oswald (2008)). New US BP
guidelines from the American Heart Association emphasise that BP screening can identify
individuals who develop elevated BP over time and that even small improvements in
population level behaviours could substantially decrease population CVD rates (Whelton
et al. (2018)). In the UK, a screening program has been implemented - the NHS health
check - but there is little evidence on whether it is cost effective.
Our analysis has two aims. First, we aim to understand whether information feedback
can change health behaviours. We focus on two of the leading risk factors for HT which
we can construct on an annual basis from our data: whether a smoker and the amount of
alcohol purchased each month. As HT is asymptomatic - even at high levels - our results
may be interpreted as stemming from an information effect and are unlikely to suffer
confounding with direct debilitating effects of the disease that for instance may prevent
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individuals working full-time. Supplementing our main results, we also study nutrition
and exercise outcomes, although they are measured at a lower frequency in our data.
Second, we analyse whether the information feedback triggered longer-term reductions in
CVD including coronary heart disease and strokes, as HT is a leading risk factor for CVD
and is the leading risk factor for coronary heart disease and strokes (WHO, 2013), the
two leading causes of death in the UK and worldwide.
Smokers are known to exhibit biased assessments of their own health and overestimate
lung cancer survival rates that suggest significant room for public health campaigns to
educate smokers about the benefits of quiting (Ziebarth (2018)). A similar ‘Dunning-
Kruger’ effect is seen in other health domains where overconfidence is highest among those
with low levels of knowledge about the causes and high levels of misinformation (eg. Motta
et al. (2018)). Information campaigns advising raised fruit and vegetable consumption or
reduced salt intake and smoking are increasingly used to improve behaviours but have had
mixed success (Griffith et al. (2017)) and it seems plausible that this is because individual’s
do not personalize risks presented in population-level terms.1. Our paper also contributes
to the literature on the behavioural effects of medical testing and feedback e.g. HIV
testing (Delavande and Kohler (2012); Thornton (2008)) and Huntington disease (Oster
et al. (2013b); Oster et al. (2013a); Oster et al. (2010)).
To identify the effect of interest we exploit two features of the survey design of Un-
derstanding Society: the UK Household Longitudinal Study (UKHLS) that included
biomarker collection including BP. First, we exploit the fact that the fieldwork period
for adjacent waves in the panel overlaps by one year giving us representative samples of
UK households in the same calendar year but at different waves in the panel and hence
with different knowledge of their BP. Second, the high BP warning/feedback is deter-
mined by a known function of a participants BP score. This gives an additional source of
variation in BP knowledge, once we account for a confounding effects related to the level
of BP. We also have annual self-reports of whether a panel respondent is formally hy-
pertensive and so use the survey feedback as an instrumental variable for the self-report.
1Psychologists refer to this as ‘illusory superiority’ - that people judge themselves superior on person-
ality traits to an average peer. See, for example, Hoorens (1993).
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We interpret our estimates as local average treatment effects (LATE), that is, we identify
the effect of information for those who update their hypertensive status as a result of
participating in the survey, but would not have done so otherwise.
We find that the high BP warning of the survey triggered formal diagnosis of HT
but for less than 100 percent of those measured high in the survey. The Figure is less
than 100 percent, at least in part, because the survey is likely to overestimate BP relative
to an assessment conducted by a GP. Still, given the low up-take of GP services by at-
risk of CVD groups, the new diagnosis triggered by the survey represent an important
improvement in health behaviours. The increases in the formal diagnosis of HT coincided
with participants revising downward subjective assessments of their physical health. We
then go on to examine the health behaviours of the group formally diagnosed as HT. Our
LATE estimates indicate large reductions in their smoking rates 6 months after the survey
feedback which persist for 3 years. However, our LATE effects imply only a small effect on
overall smoking rates of those getting a high BP warning. We find that diets marginally
improved, although the estimates are imprecise and, in contrast, we find no evidence of
reductions in alcohol spending. Finally, we examine whether the improvements in health
behaviours were large enough to improve health outcomes over the medium term. We
find important reductions in the incidence of CVD including congestive heart failure and
coronary heart disease but not strokes.
The remainder of the paper is structured as follows. Section II provides some back-
ground to HT and the UK setting. Section III describes the data, feedback and empirical
methods used in the analysis. Section IV presents the benchmark estimates, after which
Section V shows the results from several robustness checks including different specifica-
tions of our instrument and reports evidence on the heterogeneity of the effect. Section VI
concludes. Supplementary material on the data and additional results discussed through-
out the paper are available in an Online Appendix.
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2 Background: Hypertension, its measurement, and
medical guidelines
HT occurs when BP in the arteries is persistently raised. BP is measured in millimetres
of mercury (mmHg) and expressed as two readings: systolic BP measures BP when the
heart beats; and diastolic BP measures BP between beats. Worldwide, an estimated 1.13
billion people have HT and it is a major cause of premature death (WHO, 2017). It is
a leading risk factor for coronary heart disease (leading cause of death in the UK and
worldwide), stroke (second leading cause of death in the UK and worldwide), chronic
kidney disease, and aneurysm amongst others. HT is a problem in both the developed
and developing world. The prevalence of HT is 34.0 percent in the US (Benjamin et al.
(2018)) and 30 percent in the UK (Fat (2018)).
Central to our paper is the fact that HT is asymptomatic even at very high levels.
Many therefore carry the condition but will only discover they have it at a medical check-
up or if it is diagnosed during the treatment of another condition. There are exceptions as
symptoms may be present at extremely raised levels (hypertensive crisis). Symptoms of a
hypertensive crisis include headache (22%), epistaxis (17%), faintness, and psychomotor
agitation (10%) (Papadopoulos et al. (2010)). A substantial share of the UK adult popula-
tion has untreated HT although the prevalence has fallen in recent years. The prevalence
of undiagnosed HT decreased from 2003 to 2017 for both men (20 to 12 percent) and
women (16 to 11 percent) (Fat (2018)).
To diagnosis HT, BP is usually measured on more than one occasion or over a 24-hour
period and the BP readings are then compared to clinical thresholds. If BP is measured
in the clinic, as it fluctuates, multiple readings are usually taken and by the means of an
inflated cuff which is placed around the upper arm and connected to an automatic device.
The American Heart Association (AHA) recommends two to three of such readings on two
to three separate occasions. This differs from UK practice where NICE guidelines require
continuous monitoring of BP over a 24-hour period (ambulatory BP monitoring) once an
individual has initially been screened as high on an office-based measure. The thresholds
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of the AHA are: ‘normal’ systolic<120 and diastolic <80; ‘elevated/pre-hypertensive’
systolic 120-129 and diastolic <80; ‘stage 1 hypertension’ systolic 130-139 and diastolic
80-89; ‘stage 2 hypertension’ systolic 140 or higher and diastolic 90 or higher; ‘hypertensive
crisis’ systolic higher than 180 or diastolic higher than 120.
There will be differences between BP as clinically assessed (e.g. by a GP) and as
measured by a medical professional in a social science survey, such as UKHLS, even
though both represent objective measures of BP. Differently from clinical practice, in the
household survey it is typically not possible to measure BP at multiple points in time or
continuously through the day to reduce the influence of environmental factors. Environ-
mental factors affecting BP include: time of day (diurnal variation), room temperature,
behaviours around the time of measurement (e.g. smoking, exercising), the presence of
a medical professional (white coat effect), in addition to the random fluctuations in BP
as described above. In appendix A, we adjust our survey measures of BP to account
for some of the sources of difference with clinical practice. We find that on average, the
survey measures tend to overestimate BP compared to what would be measured by a GP
during office hours. For example, we show that survey respondents are more likely to have
interviews in the evening when BP is high and that a substantial share of respondents
have a home room temperature below medical guidelines that would tend to raise it. Of
those measured high in the survey, only 84.6 percent would be high according to our
adjusted readings they might obtain in a GP’s office. Conversely, we estimate that 2.8
percent of those with normal BP according to the survey will be high according to our
adjusted readings.
The benefits of lowering BP to recommended levels are well established and there is
now growing evidence that lowering it further continues to bring large reductions in CVD
risk (Ettehad et al. (2016)). Ettehad et al. (2016) conclude that a 10 mm Hg reduction
in systolic BP reduced the risk of major cardiovascular disease events by 20%, coronary
heart disease by 17%, stroke by 27%, heart failure by 28%, and all-cause mortality by 13%.
Moreover, the authors find no strong evidence that proportional effects were diminished in
people with lower baseline systolic levels (<130 mmHg). Results from a large randomised
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control trial in the US (SPRINT trials) are consistent with this finding where targeting a
systolic BP of less than 120 mm Hg, as compared with less than 140 mm Hg, resulted in
lower rates of fatal and nonfatal major cardiovascular events and death from any cause
(SPRINT Research Group (2015)).2 In this direction, the American College of Cardiology
and the American Heart Association lowered the guideline level for diagnosing and treating
HT in 2017 substantially below the UK level (to >130 mmHg in the US whereas >140
mmHg in the UK).
HT can be treated with medications and lifestyle modifications or a combination of
both. In both the US and UK, those with stage one HT and calculated to have lower CVD
risk are first treated exclusively with lifestyle advice. Typical lifestyle advice includes:
adopting a diet rich in fruits, vegetables, whole grains, and low-fat dairy foods; to reduce
excessive sodium intake, alcohol consumption, and consumption of coffee; smokers should
stop smoking; and to increase physical activity to recommend levels. In the UK, patients
should receive an annual review to discuss their lifestyle and monitor BP. Both US and
UK guidance emphasise the use of home BP monitors as a method to monitor BP.
3 Related Literature
There is a small but growing literature that examines the impact of disease diagnosis on
changes in health and related behaviours. The closest paper to ours is by Zhao et al.
(2013) who examine the impact of a HT diagnosis on diet. They use a sharp regression
discontinuity design using panel data from China and find that people reduce their intake
of fat in the 12 months immediately after a HT diagnosis. This effect is largest, and only
statistically significant, among the richest third of the population, however there are no
differences in the effect by education. Edwards (2016) examines the provision of a range
of information related to several biomarkers such as BP, haemoglobin A1c, and total and
HDL cholesterol. Very high BP levels (at or above 160 mmHg systolic or 110 diastolic)
2Indeed, the intervention was stopped early after a median follow-up of 3.26 years owing to a sig-
nificantly lower rate of the composite outcome (myocardial infarction, other acute coronary syndromes,
stroke, heart failure, or death from cardiovascular causes) in the intensive-treatment group than in the
standard-treatment group.
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were immediately fed back to the individual whereas other markers were given to the
individuals by the form of a letter. He finds, using a fixed effects panel methodology, that
on average there were small effects of the provision of biomarkers and indeed there is some
evidence of a reduction in health care utilisation. For those who received information on
their biomarkers that were in the high and dangerous categories there was an increase
in pharmaceutical use, and he finds small degree of weight-loss for those with a diabetes
diagnosis.
Other papers have not used a HT diagnosis but have examined other diseases or
biomarkers. Carrera et al. (Forthcoming) examine whether the provision tailored health
information in relation to cholesterol levels has any impact on food choices among hospital
workers in the US. Hospital workers were incentivized to undertake a Health Risk Assess-
ment (HRA), biometric health screening tests, to measure various health characteristics.
The HRA covers measures of cholesterol, glucose, BP and BMI (although the authors
focus solely on cholesterol levels). By combining these measures together with weekly
food purchases from the hospital cafeteria both before and after the HRA. They find the
impact of the information is greater for those who are medically trained. In particular, the
results show a statistically significant decline in total spending on food purchases among
those who were diagnosed as ‘high risk’, this is most pronounced among those who were
unaware of their elevated cholesterol level. In addition, they find a significant increase in
the proportion of healthy items purchased among high-risk participants over the age of
55 and women.
Another closely related paper is by Oster (2018) who uses scanner data from house-
holds to look at the impact of diabetes diagnosis on food purchases. In this paper,
individual diagnosis of diabetes in inferred from purchases of glucose testing products
(like glucose monitors) that show up on the household scanning data over time, since
such items are required in order to manage their disease and track their blood sugar lev-
els. The results show that, post-diagnosis, households record a statistically significant yet
small drop in calories purchased, while in the first month healthy food purchases increase
while unhealthy foods decrease, although only this latter effect persists over time.
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There is a related literature that focuses on the provision of health and nutritional
information to consumers and its impact on diet. Wisdom et al. (2010) find that providing
calorie content information on menus at Subway restaurants reduced calorific intake by
approximately 7%. Similarly, Bollinger et al. (2011) look at calorie posting at another
chain restaurant, this time Starbucks, with results showing that although average calories
per transaction fell by around 6%, this was solely driven by changes in food choices, with
zero impact on drinks.
This paper is also related to the literature on uncertainty and updating of beliefs
regarding people’s health and associated behaviors. The lack of knowledge and uncertainty
regarding health or disease incidence is well-documented (e.g. Crossley and Kennedy, 2002
and Barrett-Connor et al., 2011), as is the general lack of awareness regarding lifestyle
risk factors (e.g. Sanderson et al., 2009). In both cases, standard economic theory would
suggest that people will, when faced with new health information, update their beliefs and
undertake healthier choices, as suggested by the evidence presented in studies like Carrera
et al. (Forthcoming) and Zhao et al. (2013). However, there is also evidence to suggest
that when it comes to certain health-related behaviors, people actually overestimate the
risks involved in terms of falling ill or contracting a disease. For example, Viscusi and
Hakes (2008) report that adults on average overestimate the lung cancer risks of smoking,
as well as the mortality risks and life expectancy losses. The authors find that higher risk
beliefs reduce the likelihood of starting to smoke and increase the probability of smoking
cessation among smokers. It follows that new information regarding the true risks of
smoking would lead to an increase in smoking and reduced efforts to quit.
Our paper has important differences when compared to these studies, both in terms
of design and scope. First, as we have annual measures of whether HT has been formally
diagnosed by a health care professional (rather than the survey nurse), we are able to
instrument formal HT using the survey feedback as an instrumental variable. This setup
allows us to account for the possibility that participants measured as high by the survey
do not go on to be formally diagnosed by a healthcare professional. Second, our BP
feedback comes with a clear interpretation of the measured BP score and its significance,
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unlike the previous studies where only the BP reading was given to participants. Zhao
et al. (2013) claim that HT cut-offs are common knowledge in China with adults getting
this information from doctors, media outlets as well as the internet. However, evidence
indicates this is not the case in the UK. Slark et al. (2014) find that 52% of their sample
of over 1000 individuals do not know the acceptable range for BP. Unlike us, Zhao et al.
(2013) have more detailed information on diet, being able to examine different macronu-
trients (such as fats and carbohydrates), however we examine a wider range of modifiable
behaviours that contribute to HT such as alcohol consumption (spending on alcohol), reg-
ular exercise, and smoking. Even though data limitations mean we miss specific elements
of diet consumption, we do have information on various food groups, as such we have
a broader range compared to much of the related literature. The sample we consider is
also representative of the wider population, which is not the case in the earlier studies.
Edwards (2016) examines an exclusively older population of those aged 50 and above and
Carrera et al. (Forthcoming)’s sample are those who work in a hospital who might be
more sensitive to the provision of health information. Third, we follow participants for up
to five years after feedback and so can look at the persistence of any behavioral effects.
Finally, and perhaps most importantly, we can observe health outcomes allowing us to
study the final impact of information on CVD.
4 Data and Methods
4.1 UKHLS Survey Data and the Personalised Blood Pressure
Feedback
This subsection describes our survey data. It places emphasis on the BP measures col-
lected by a trained nurse, variation in the subsequent (one-off) personalised feedback
delivered to survey participants and the construction of our analysis sample.
We use data on adults aged at least 16 from the first eight waves of UKHLS that
began in 2009. The UKHLS is a large panel survey that subsumed and expanded on
the former British Household Panel Survey (BHPS) that began in 1991. It links rich
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individual panel data on socio-economic variables, with objectively measured biomarkers.
The socio-economic variables - including health behaviours and outcomes (smoking, al-
cohol spending, physical activity, diet, physical and mental health) - are collected in an
annual face to face interview. The biomarker collection was a one-off and collected by
a trained nurse during specially designed home visits. The collected biomarkers are BP,
anthropometrics, grip strength, lung function, prescribed medications and blood sam-
ples. Collected in the annual interviews are self-reports of whether a participant has been
formally diagnosed with HT by their GP or other health care professional. The data
therefore allows us to distinguish between objectively measured BP at a point in time
(i.e. the one-off biomarker), and participants own knowledge of whether they have been
formally diagnosed with the condition as determined by their GP or similar (i.e.. the
annual self-report).
Survey respondents measured to have high BP were given feedback and advised to
visit their GP. Given the centrality of the feedback to our paper, we discuss the details of
it below.
There are two ways that the survey generates exogenous variation in the feedback
which participants receive. First, the timing of the data collection implies a feedback
gap as, at a given point in time, some participants have completed the nurse visit and
hence have received feedback, whilst others have not. Notionally, the survey includes
two random samples drawn from the GB population g = 1, 2. For g = 1, participants
enter the panel at time t, whereas group 2 enters at t+1. Participants are interviewed
annually and both groups receive the nurse visit and feedback approximately five months
after their second annual interview.3 As g = 1 entered the panel in 2009, this implies
a feedback gap opens up in 2011, as g=1 has participated in the biomarker collection
and received feedback approximately 7 months ago, whereas g=2 is yet to take part. By
2012, both groups had participated in the biomarker collection and the feedback gap had
closed. Figure 1 illustrates the issue graphically. Also, shown in the Figure is a third
group (g=3) that corresponds to the former BHPS that enters UKHLS in 2010.4 g=3
3Figure B1 shows the distribution of the months between the second interview and nurse visit.
4The BHPS was a representative sample of the Great Britain household population in 1991. The
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likewise took part in the biomarker collection between their second and third interviews
and we include it in our main analysis sample. In what follows, we present ’baseline’
measures by merging information collected from the second annual interview with the
data collected by the nurse.
Second, variation in feedback is generated by the feedback rules that are a function of
the participants measured BP. BP was measured three times by the survey nurse and the
feedback was based on the minimum of the second two readings. Specifically, participants
were allocated to one of four categories and for each category the nurse read a standardised
statement during their visit. The statements referred to the level of BP and guidance on
how urgently a participant should visit their GP. The categories and guidance were: i.)
normal, ii.) mildly raised and visit GP within 2 months, iii.) raised and visit GP within
2 weeks, and iv.) considerably raised and visit GP within five days (the threshold values
were chosen based on guidelines from the British Hypertension Society and are listed in
Table B2).
The oral feedback given to participants constituted a readily understandable person-
alised at-risk warning.5 In addition to the verbal statements given by the nurse, partici-
pants received a written record in the form of a ‘Measurement Record Card’ (Figure B2).
Additionally, in the cases allocated to the ‘considerably raised’ category the survey doctor
telephoned and wrote to participants to advise them to visit their GP within five days.
Participants therefore received a clear indication of their BP reading and its significance.
Our design suffers from non-compliance as not all respondents were willing to partici-
pate in the biomarker collection. Of the 35,501 eligible individuals6, 20,684 agreed to take
part while a further 450 did not produce 3 valid BP readings. The overall consent rate was
therefore 57.0 percent. Non-consenters tended to be younger, less educated, more likely
following rules mimic the demographic processes by which the population is reproduced, including births
and deaths, partnership formations and dissolutions, and emigration. The sample therefore remains
representative of the GB population as it changes over time, subject to adjusting for attrition.
5In contrast to height, weight, percentage body fat and grip strength for which nurses were strictly
prohibited from interpreting the results. For these biomarkers, participants received a record of the
measured value.
6All UKHLS sample members who took part in the annual survey interview preceding the biomarker
collection were eligible, excluding pregnant women, those ill/physically unable, those residing in Northern
Ireland and, on cost grounds, a small random sample of English postal sectors in group 2.
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to be employed, have better self-reported health and were less likely to have reported HT
(Table B1). We drop from the consenting sample 1387 individuals (6.9 percent) for whom
it was not possible to construct reported HT histories because of a refusal to answer the
relevant question in at least one wave.7 This leaves us with a baseline sample of 18,847
individuals (8410 in group one, 5843 in group two and 4594 in group three). 15,509 (82.3
percent) were measured by the survey nurse to have ‘normal’ BP; 2692 (14.3 percent) to
be ‘mildly raised’; 575 (3.1 percent) ‘raised’ and 71 (0.4 percent) ‘considerably raised’. We
focus our main analysis on the sample of individuals who are interviewed at most seven
times (waves 1-7 for groups one and two and waves 2-8 for group three). This means for
each individual we have up to two pre-nurse visit data points and five post nurse visit
data points.
Our design suffers from attrition, although not excessively so. Of our baseline sample,
12,611 (67 percent) took part in all seven interviews, and over 90 percent took part in
at least four interviews. In robustness checks we examine the sensitivity of our results to
attrition.
We study a specific set of health outcomes and health behaviours which are the target
of HT advice. The outcomes and behaviours we study are derived from self-reports made
during the survey interviewers. Health behaviours we study are: the number of fruit and
vegetable portions usually consumed per day (participants were shown pictures to help
define portion size); whether a current smoker (constructed retrospectively); household
monthly spending on alcohol; whether physically inactive (has not walked at least 10
minutes in the last month and reports being physically inactive); self-reported physical
activity ranking (scale 0-10); and a bad diet indicator (consumes mainly whole fat milk
(rather than semi-skimmed or skimmed) and white bread (rather than brown or wholemeal
bread)). The health outcomes we consider are validated physical and mental health
functioning scores from the short form 12-item Survey (SF-12) and indicator variables for
7g=3 were asked a slightly different question in their annual BHPS interviews before they entered
UKHLS. The question referred to having ‘Heart/blood pressure or blood circulation problems’. As this
is a broader definition of HT, it may mean we over-estimate the prevalence of known HT for this group
and under-estimate new cases of it. To confirm our results are not sensitive to this differing definition,
we remove g=3 from our sample in sensitivity checks.
14
ever being diagnosed with a specific chronic condition by time t (congestive heart failure,
coronary heart disease, angina, heart attack, and stroke). Not all of the variables are
measured annually, rather some are collected on a rotating basis once every few waves.
This means they are collected at different distances from the BP feedback. Table C1
summarises the frequency and timing of the variable collection and appendix C provides
exact details of the survey questions and how we constructed our final outcome variables.
4.2 Baseline Statistics: Hypertension prevalence, the knowledge
gap and health behaviours
We begin by documenting a basic fact that HT and undiagnosed HT is common. Figure
2 presents prevalence rates at baseline for different population subgroups of interest. We
count as HT anyone who ever self-reported it in the survey by the time of the nurse visit
or who was measured high by the nurse. The Figure decomposes the HT into 3 component
parts: those measured high by the survey nurse and who previously reported HT (HT
confirmed), those measured normal by the survey nurse who previously self-reported it
(HT controlled), and those measured HT by the survey nurse who did not previously know
they were HT (HT negative shock). The overall prevalence of HT in the population is
calculated to be 35.0 percent. It is highest amongst those aged 50 and over (54 percent),
with above median income (42.7 percent), without a degree level education (38.3 percent),
and male (36.5 percent). 9.5 percent of the population received a negative HT shock from
the survey nurse, that is, they have high BP but did not know it. The share receiving a
negative shock is highest among African and black Caribbean (13.1 percent), those aged
50 and over (12.7 percent), males (11.6 percent), those with above median income (10.6
percent) and those without a degree (9.8 percent).8
There are compositional differences between the overall HT population and the nor-
motensive; but also between the HT negative shock group and the HT controlled group.
8Our prevalence estimates line-up reasonably well with official statistics derived from the Health Survey
for England. The official estimates show that HT prevalence ranged from 29-30 percent between 2005
and 2014 and that the proportion of adults with untreated HT (similar to our ‘HT negative shock’ group)
decreased from 2003 to 2017 for both men (20 to 12 percent) and women (16 to 11 percent) (Fat (2018)).
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Tables 1 and 2 show demographic comparisons. Table 1 shows that the HT compared
to the normotensive are on average older (61 vs. 46), more likely to be male (48 vs. 41
percent), more likely to be white (96 vs. 93 percent), less educated (16 vs. 25 percent
with a degree), and are poorer (mean monthly income of £2397 vs. £2941). Table 2
compares demographics for the HT negative shock group and the HT controlled group.
Those with HT who got a negative shock are younger (58 vs 63), more likely to be male
(55 vs. 45 percent), richer (mean monthly income of £2701 vs. £2284), and tend to be
more educated (e.g. 19 vs. 14 percent with a degree).
There is a baseline gap in behaviours and outcomes, conditional on demographic con-
trols, consistent with what participants know about their HT status. Table 3 shows
regression estimates where we regress our health outcomes on demographic controls and
dummy variables for HT status. Compared to the non-hypertensive, those who knew
they were hypertensive (column 2) report worse physical and mental health, have higher
measured BP, but report better diets with a mixed picture on having a sedentary lifestyle.
Column 4 tests for differences between the hypertensive that did and did not know. We
see that those who are HT and did not know have higher measured BP but report better
physical and mental health while showing higher smoking rates and worse diets. The HT
that did not know therefore show worse behaviour at baseline than their better-informed
counterparts and so in principle there is a role for information feedback to close the gap
in behaviours. The next Section presents our empirical strategy for determining whether
information feedback could help close some of the behaviour gap between the hypertensive
that knew and the negative shock group.
4.3 Estimation strategy
This subsection outlines how we use the survey feedback to identify the causal effect of
(clinical) information on health behaviours and outcomes. Underpinning our empirical
strategy is the notion that the survey feedback would trigger visits to a GP where a clinical
diagnosis would be made. A clinical diagnosis by a GP would lead to lifestyle advice,
monitoring and where appropriate the prescribing of BP medications. We implement an
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IV strategy that exploits the survey feedback to instrument for a formal GP diagnosis of
the condition. We identify the effect for compliers (i.e.. those for who survey feedback
triggered a GP diagnosis of HT but would not have been diagnosed otherwise) in a LATE
framework.
The difficulty in estimating our relationship of interest is that knowledge of one’s
clinical health status is likely to be correlated with other unobservable characteristics
that also effect health behaviours and outcomes. For example, those with extremely
high BP may show debilitating symptoms and be more likely to seek a diagnosis from
their GP. This would induce a negative correlation between reported HT and good health
behaviours such as exercise. On the other hand, the health-conscious may show good
health behaviours and at the same time be better informed about their HT status (say if
they take-up GP health checks), leading to the reverse correlation.
The ideal instrumental variable induces variation in knowledge of ones HT status but
it is uncorrelated with other individual characteristics that effect health behaviours and
outcomes. To instrument for whether a person has been formally diagnosed with HT,
we use the variation in the timing of the survey feedback exogenously determined by the
survey design and whether a participant was told to visit their GP, determined by their
observable BP score (Section 4.1).
Our first stage equation is:
HypertensiveGPit = αi + δ1Instrumentit +Xitβ + τt + ϵit (1)
HypertensiveGPit indicates reporting a GP diagnosis of HT by time t and, as the
interest is in the effect of the survey feedback on own health knowledge, it is fixed after
feedback at the first post-feedback value9; Xit is a set of time-varying controls10; αi an
individual fixed effect that captures time invariant characteristics including BP if it is fixed
9We have also allowed HypertensiveGPit to vary after the information feedback, the first stage F-stat
is typically smaller but broad conclusions hold.
10The controls are: age, age-squared, age-cubed, relationship status (married), employment status,
household size, housing type. The overlapping sample design of UKHLS also allows us to also include
wave fixed effects, to account for the possibility of differences in reporting behaviour (eg. questionnaire
changes) across waves.
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in the short-term; and instrumentit is a dummy variable equal to one if allocated to one of
the ‘high’ BP categories by the survey nurse and in a post feedback period. Identification
comes from differences in the timing of the feedback across different subsamples of the
survey and the fact that only those over the BP threshold received a high BP warning
from the survey nurse.
Figure 3 shows a simplified picture of the first stage and it confirms that the BP
feedback of the nurse (occurring at time zero in the Figure) triggered new diagnoses of
HT as measured by the annual self-reports in the survey. Panel A of the Figure isolates
new diagnosis of HT by showing, by feedback of the nurse, the share of participants not
reporting HT by t-1 who newly report HT at time t (ie. HT entry rates). According to
this measure, new diagnoses of HT peak six months after the survey feedback and return
to their pre-feedback levels thereafter. The increases/peaks show a monotonic pattern
with them being largest for those measured by the nurse as considerably raised (entry
rate increases from 15% six months before feedback to 57% six months after), followed by
raised (entry rate increases from 7% six months before feedback to 22% six months after),
and then mildly raised (entry rate increases from 5% six months before feedback to 7%
six months after); while no peak is seen for those measured as normal (which is split into
normal high and normal low in the Figure). Also notable is the fact that the entry rates
never reach one showing that not all people measured high in the survey subsequently
received a diagnosis by their GP. Panel B shows the prevalence of reported HT in each
feedback group around feedback. Those measured and assigned to the highest BP groups,
prior to feedback, were more likely to report HT and show parallel but slightly increasing
trends but six months after feedback, the gaps to the normal feedback groups increase
and remain stable thereafter. The prevalence of reported HT for each group six months
before and six months after feedback are as follows: ‘considerably raised’ 52% and 80%;
‘raised’ 51% and 62%; ‘mildly raised’ 44% and 48%; ‘normal high’ 37% and 39%; ‘Normal
low’ 18% and 19%.
A concern might be that the post-feedback jumps in reported HT are a direct response
to the feedback, rather than reflecting an increase in formal diagnosis of the condition
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from a GP. Such an interpretation can be ruled out for several reasons. First, a direct
response implies that participants measured high in the survey should all report being
HT after feedback, yet the share doing so remains well below one. Second, under a direct
response we would expect a similar jump for all those receiving a high feedback, but what
is observed is a monotonic pattern with the biggest jumps occurring for participants given
the most serious feedback types. This pattern is however consistent with the measure-
ment issues discussed in Appendix A where misclassification means that a share of those
measured HT in the survey turnout not to be HT when measured by their GP. Third,
the survey is conducted face-to-face with trained interviewers who are there to advise
respondents on the correct interpretation of the survey questions (i.e.. that the questions
do not relate to the survey feedback).
In the second stage we estimate:
Outcomeit = αi + δ1 ̂Diagnosed with HBPit +Xitβ + τt + ϵit (2)
where Diagnosed with HBPit is the fitted value estimated from equation (1). Here we
estimate a Local Average Treatment Effect (LATE), that is we estimate the impact on
health behaviours of receiving a formal GP diagnosis of HT triggered by the survey nurse
visit, but that would not have been diagnosed otherwise.
For our approach to be valid we need to maintain two identifying assumptions. The
first, the exclusion restriction, is that conditional on Xit and αi, receiving a high BP
feedback is uncorrelated with characteristics that affect health behaviours and outcomes.
The inclusion of the individual fixed effects, αi, in the model accounts for the fact that
the feedback, as it is a function of the BP level, will be correlated with other time-
invariant characteristics that effect health outcomes. Differently, the inclusion of a range
of time varying controls in Xit allows us to account for the possibility that there are
time varying variables that may be correlated with the feedback/BP level and also effect
health outcomes ie. differing trends by BP level. Finally, presented alongside the main
results are estimates from models that further include trend terms for X, Y and Z, to
account for the possibility of different trends in the outcome by BP level. To check the
19
validity of the exclusion restriction, we estimated equation (1) but replaced the dependent
variable with indicators for receiving a diagnosis of one of 10 other health conditions
that are unrelated to HT. If the exclusion restriction is violated, we might expect our
instrument to be predictive of the other diagnoses and not just HT. The coefficients and
their corresponding 95% confidence intervals are presented in Figure 4, while in Figure
5 we present the F-statistic of the excluded instruments. The results are consistent with
the instrument leading to new diagnosis of HT, but not of other health conditions. Two
of the coefficients presented are statistically indistinguishable from zero and of the two
estimates that are statistically significant (aside from the coefficient on HT) all are very
small in magnitude. The only F-statistic above 10 is when the dependent variable refers to
diagnosis of HT (indeed, this statistic is very large being over 100). To check against the
possibility of differential trends contaminating the main results, we perform robustness
checks where we construct a sample of individuals with similar levels of BP by removing
those with the lowest measured BP from the sample (Section 5.4).
The second part of the exclusion restriction requires that the instrument only effects
the outcome through the first-stage, and not directly. In principle there could be a
direct effect if participants did not follow the survey advice to visit their GP, and self
treated instead. As the survey feedback was not a definitive HT diagnosis and this was
communicated to participants, we judge that any such effect is likely to be small.
The second assumption, monotonicity, requires that the relationship between the in-
strument (receiving a high-BP feedback from the survey) and the endogenous variable
(being diagnosed as clinically HT by their GP) is monotonic. This assumption requires
that getting a high feedback from the survey can never make it less likely that an indi-
vidual gets clinically diagnosed as HT by their GP.
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5 Results
5.1 Health Behaviours
We begin by showing the initial effect of the HT diagnosis on two health behaviours
that we have measures of each year (smoking and spending on alcohol). Specifically, the
estimates shown in Table 4 report the impact 6 months after the nurse visit. The OLS
estimates show a negative but imprecisely estimated association between smoking and
having ever been clinically diagnosed with HT. The next column reports the reduced
form (RF) estimates - this is the impact of the instrument (i.e. the nurse diagnosing HT
after the visit) directly on the probability of smoking. Here we find a reduction in smoking
by 0.5 percentage points. The final column shows the FE-IV estimates. Scaling the RF
estimates by a factor of 20 (as the nurse visit results in someone being told they have HT
led to a 5 percentage point increase in the self-reported clinical diagnosis of HT) leads to a
FE-IV estimate of around a nine percentage point reduction in smoking. For context the
mean shows the proportion in the sample who smoking who are “at-risk” of developing
HT is 30% - the effect size we then find is then around a 30% reduction in the smoking
rate for this group. While these effects appear large, and they are, it is important to re-
emphasize what we estimate is a Local Average Treatment Effects (LATE), such that the
impact we find are on those who update their HT status (and get a clinical diagnosis) as a
result of the nurse visit and would not have done otherwise - this group are perhaps those
not likely to go to the doctor and get a diagnosis in normal circumstances. Therefore, the
impact of information for this group on the margin is large and larger that the average
effect for the population.
Our treatment was an personalised information treatment which involved medical
professionals, however the information itself was not directly related to smoking nor was
a smoking cessation programme. However, it is still useful to compare our estimates
to smoking cessation programmes. Two Cochrane reviews present evidence on smoking
cessation interventions led by nurses (Hill Rice et al., 2017) and by physicians (Stead et
al., 2013). Hill Rice et al. (2017) review 44 RCTs comparing the difference between high
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intensity interventions, which includes an initial contact of more than 10 minutes with
additional materials and/or strategies other than simple leaflets and additional follow-
up visits and low intensity interventions which primarily inlcude providing advice (with
or without a leaflet) during single consultation lasting 10 minutes or less with up to one
follow-up visit. They find a relative risk effect on smoking cessation 1.29 and 1.27 for high
and low intensity respectively. When physicians deliver advice, the effect increased such
that high intensity interventions lead to a 1.86 relative risk increase in smoking cessation
and 1.66 for less intense programmes. Therefore, while at first glance our estimates appear
large they are on out of step with interventions that directly target smoking.
We next move onto how this effect evolves over time. Figure 6 shows the causal impact
of the HT diagnosis (i.e. the FE-IV estimates) on the probability of smoking at 6 months
and then at 12 month intervals up to 30 months11 the nurse visit and then for data pooled
together using the latest wave i.e. at 30 months. In the pooled sample we also allow the
outcomes those with different HT statuses (i. mildly raised and ii. raised and considerably
raised) to have a different trend. The points for the period at -6 and -18 months indicate
that the participants have not received information yet so are set to zero.
The diagnosis leads to a reduction in smoking. There is initially a 9 percentage point
drop in the probability of smoking 6 months after the diagnosis - repeating the analysis in
Table 4. This then increases to 14 and 20 percentage points 18 and 30 months after the
diagnosis respectively, the pooled sample however is close to the effect at 12 months. The
pooled estimate becomes imprecisely estimated when we include the two trend variables,
although the point estimate is similar to that at 6 months. In general, we cannot however
distinguish between the effects at periods, i.e. the confidence intervals overlap to the
extent that we cannot say that the impact at 6 months is significantly different from that
at 12 months or 18 months.
In contrast, we do not find statistically significant impact on alcohol consumption.
The evolution of the estimates for alcohol consumption are shown in Figure 7. We find a
positive but imprecisely estimated increase in alcohol consumption up to 42 months after
11Due to a change in the definition of the variable we cannot examine beyond 30 months after the nurse
visit for smoking but can examine up to 54 months for other outcomes.
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the feedback, these effects range from around 10 to 50 pounds. The pooled estimate is
of similar value, and is similarly not statistically significant, including the trends increase
this value but it remains imprecise. At 54 months the estimate is a fall by pound and
again not precisely estimated. Therefore, overall we find, if anything, a positive effect but
this is insignificant.
We are also able to examine a wide range of health outcomes that are not measured
each year but instead are only captured in waves 2 and 5. These variables are described in
more detail in the data appendix. In summary, we can investigate eating patterns (these
cover fruit and vegetable consumption, and the type of bread and milk) as well as measures
of physical activity. We have chosen health behaviours that medical professionals advise
in order to prevent or reduce the incidence of HT12. We combine some of the behaviours
together. “Bad diet (indicator)” indicates that an individual does at least one of the
following: drinks whole milk or eats white bread. “Bad diet (intensity)” takes a one if
they do one of drinks whole milk or eats white bread and a two if they do both. “Sedentary
lifestyle”’ indicates whether someone has not walked for more than 10 minutes over the
last 4 weeks and/or they play no sport at all. We also try to capture the extent to which
individual engage physical activity using a variable that captures a continuous ranking
(form 0 indicating very active to 10 indicating inactive).
Table 4 presents these results. We find a reduction in the probability of eating less than
5 fruits and vegetables a day. The RF point estimate is a two percentage point reduction,
with the IV implying a large 36 percentage point reduction among the compliers. Both of
these estimates are significant at the 10% level and are relatively imprecisely estimated.
The measures of bad diet and physical activity do not show a consistent pattern, none
being statistically significant.
5.2 Health Outcomes
We next turn to health outcomes. First, we report estimates from two measures of self-
reported health. These are the physical and mental health scores from the short Form
12urlhttps://www.who.int/news-room/fact-sheets/detail/hypertension
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12-item Survey (SF-12). Second, we consider whether being diagnosed with HT causally
leads to subsequently being diagnosed with cardiovascular disease (CVD). In both cases
we consider the longer run effects as these make take time to subsequently develop and
given, we consider this longer time period we allow those with different HT statuses (either
mildly raised or raised and considerably raised) to have a different trends.
In Table 4 we show that there is a negative correlation between HT status and self-
reported physical health which is statistically significant. The IV estimate increases in
magnitude, but the standard errors also increase, and the estimate is not precisely esti-
mated. Similarly, the IV estimate for the mental health score is not statistically signif-
icant. Turning to CVD and the specific CVD conditions. The OLS suggests there is a
positive correlation between CVD and HT, those who report having HT are 3 percentage
points more likely to report having CVD. When we instrument HT, we find a negative
effect, i.e we find are for those who update their HT status (and get a clinical diagnosis)
as a result of the nurse visit and would not have done otherwise are less likely to report
a CVD diagnosis. This is mainly due to reductions congestive heart failure and coronary
heart disease which are precisely estimated. There is also a negative impact on strokes,
but these are not statistically significant.
5.3 Heterogeneity
In this Section we consider various groups for whom the information on their HT status
might have differing effects.
Gender — There is evidence that women are more likely to be engaged in healthy be-
haviours and are more likely to seek out health information (Courtenay et al. (2002)). It
is also the case that HT rates are lower for women. These differences exist due to both
behavioural and biological differences (Dustan (1996)). Given these differences, and that
levels of awareness of HT are greater among women (Pereira et al. (2009)), it is interesting
to examine whether there are any differences by gender. We present the FE-IV estimates
for men and women in in Table 5 each for three different specifications. The first is on
the immediate effect 6 months after the nurse visit, the next column we include all the
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time periods up to 30 months after for smoking and 54 months for the other outcomes
- the “pooled” sample. The final specification is also on the pooled sample but also in-
cludes trends allowing those with different levels of HT to differ. We find a statistically
significant impact of the diagnosis on the reaction of smoking of men but not women. We
find an immediate effect of 15 percentage points, which increases in the pooled sample.
The inclusion of HT trends results in a slightly lower (ten percentage point decrease) and
imprecise estimate. There also appears to be some impact on congestive heart failure (for
females) and coronary heart disease (for males).
Education — One of the key assumptions behind the model of health capital (Grossman
(1972)) is that those with more education are more efficient at processing information.
Better educated individuals may have greater awareness and understanding of the dangers
of HT and may be better placed to seek out ways in which to tackle the problem. They
also might have greater access to health and medical care which makes them more likely
to react to the information. On the other hand, they might be better informed about their
BP to start with and so less likely to react to the information. We explore the impact of
the HT diagnosis by different education levels. Specifically, we split the sample by having
A-levels or not. We present the results in Table 6 We do not find a different impact of
HT diagnosis by education level. There is a larger reduction in self-reported health status
(SF-12 physical) for those who have more education. This might indicate that they have
understood, and taken on board, the information, more than those who less education.
Age — HT is more likely as people get older. Therefore, as one ages one may become
more sensitive to health information related to this condition. Conversely, being informed
about having HT at a younger age may come as a greater surprise and as such my trigger a
greater change in health behaviour. We examine the impact of the HT diagnosis on those
who are aged above 40, 50 and 60. Table 7 presents the IV estimates for the three different
specifications, as above. We find a negative and significant reduction in the probability
of smoking for all three age groups (the pooled sample with trend is also negative but in
each case is imprecisely estimated), as the age group increases in age the point estimate
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becomes larger in absolute magnitude. This is also the case for congestive heart failure
and coronary heart disease.
5.4 Robustness
We have performed a series of robustness checks on our main results. Figures 12 and
appendix Figures B3–B11 present the estimates for our outcomes for the different specifi-
cations that we have considered. First, each of the Figure has the corresponding baseline
FE-IV estimate. Next we consider the role that other feedback may have played. As part
of the nurse visit, individuals also received feedback on their weight, percentage body
fat and waist measurements but for these measures the nurses were strictly prohibited
from interpreting the results and just received a record of the measured value. However,
they could still influence behaviour particularly if the feedback on the other biomarkers
is correlated with the HT feedback. Therefore, the next three estimates show the impact
of controlling for getting these feedback after the nurse visit, and the fourth controls for
all three types of feedback. Diabetes is a common co-morbidity of HT, so we examine the
impact when controlling for diabetes. Next we exclude those with high and low systolic
BP in order to make sure we are not including those who might be suffering from ob-
servable symptoms of very high (such as headaches or chest pain) or very low (dizziness,
light-headedness or fainting) BP as these people might seek out medical attention that is
unrelated to the feedback associated with the survey.
When we estimate the impact over the longer run we also include additional trends.
In their discussion of difference-in-differences Kahn-Lang and Lang (forthcoming) suggest
allowing trends to depend on group characteristics. The characteristics of these groups
may be correlated with having high or low BP. Therefore, we include group specific trends
for BMI, diabetes, claiming disability benefits, physical activity, sex, and being from a
black Caribbean background. The inclusion of these group specific trends does not have
an impact on the smoking results. The inclusion of the HT group trends does have an
impact, the point estimates fall but are within a similar range to the immediate effect
they do become less precisely estimated and are statistically insignificant.
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6 Discussion and conclusions
There is evidence that people do not recognize the existence or severity of chronic disease
conditions, many of which are asymptomatic. A key question for public policy is whether
people would behave differently if they were better informed about their health. This
paper has exploited features of a household survey, that included a BP data collection
and feedback of results, as a quasi-experiment to present causal evidence on the effects of
receiving personalised health information on health behaviours and outcomes.
There is a fairly large group in the population who are not well informed about their
health but appear to respond well to receiving personalised information about it. In
particular, 9.5 percent of the population had undiagnosed HT but when they learnt from
the survey that their BP was high many of them went on to get a formal diagnosis of the
condition from their GP. At baseline, only 45 percent of survey participants who were
measured as having high BP reported the condition, but the causal effect of the feedback
was to increase this Figure by 6 percentage points 6 months after feedback. Our evidence
thus points to the importance of personalised information in reaching groups currently not
engaging with the public health system. It is not that they are unresponsive to information
or do not care about their health, but rather, they were ill informed at baseline.
Not all of those receiving a high survey feedback, go on to get a formal diagnosis of
the condition from their GP and measurement error, rather than an unresponsiveness
of participants to information, can explain a large part of this fact. In particular, the
effects on BP of time, room temperature, behaviours around the time of measurement,
the presence of a medical practitioner (white coat effects) and random noise in any group
of BP measures can result in misclassification where a participant measured high in the
survey will not be measured high according to a similar group of measures collected in
a GP’s office hours. Adjusting the survey measures for these factors, leads us to believe
that only 85 percent of the survey HT will be measured high in the office by their GP. The
measurement issues identified, more generally, point to the challenges of measurement for
the analysis of biomarkers by economists. For example, in so far as the measurement
differences may have an SES gradient future work might consider their impacts on SES
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gradients in BP. Other biomarkers, and not just BP, are a function of environmental
conditions and so the findings have relevance beyond BP.
Perhaps our most important finding is that the BP feedback lead to a change in
health behaviour by survey participants. Our preferred estimates imply that a formal
HT diagnosis from a GP leads to large reductions in smoking (10 ppt 6 months after
feedback compared to a smoking rate of 30 percent for an ‘at-risk’ of smoking group).
The smoking reductions imply large improvements in cardiovascular health (associations
in our data indicate that being a current smoker increases the risk of CVD incidence by
46 percent in the group with high measured BP). Differently, we do not find evidence of
reductions in alcohol spending nor exercise. We do find some evidence of people adopting a
healthier diet, although these effects are imprecisely estimated. Unlike generic information
campaigns that have been met with mixed success (Griffith et al. (2017)), we therefore
find an important role for person specific health information interventions in changing
behaviour. One question is why large effects are seen for smoking but much small ones
are seen for the other health behaviours. One reason, consistent with a literature in
psychology, is that is easier to stop something bad than to start something good. The
observed changes in health behaviours were large enough to change health outcomes. We
find reductions in CVD incidence of 11 percentage points or around 30 percent of the
baseline mean.
There are reasons to believe our results have external validity. They are relevant to
understanding the potential of recent initiatives such as the NHS Health Check which
offers those aged between 40 and 74 a diagnostic check for heart disease, stroke, diabetes,
kidney disease and some forms of dementia with a view to identifying risks early in the life
course. The NHS health check, like our biomarker collection, suffers from non-take up.
Non-take up of the NHS health check is of a comparable magnitude to the refusals in our
sample (50 and 58 percent, respectively), and both groups are of a similar composition
(older and more affluent). There is therefore reason to think that the results of the
paper are informative about the types of behavioural responses that might be induced by
the NHS health check. Our findings are also relevant for the understanding the efficacy
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Health Risk Assessments (HRA) and online health tools which provide tailored health
information based on lifestyle, family history and socio-economic characteristics.13
Finally, we note that there are many areas outside of health where behaviour change
might be inhibited as people believe they are ‘normal’ in some sense e.g. belief about in-
come, driving ability, weight, intelligence, skill level, attitudes, environmental behaviours.
Our findings point to the possibility that person specific information may be effective at
changing behaviours in those settings too, where general info campaigns have been inef-
fective.
13For example: The British Heart Foundation (BHF) in the UK provides an online tool that
will allow an individual to calculate their heart age www.bhf.org.uk/heart-health/risk-factors/
check-your-heart-age, a similar tool is provided by the American Heart Association and the Amer-
ican Stroke Association www.heart.org/HEARTORG/Conditions/My-Life-Check---Lifes-Simple-7_
UCM_471453_Article.jsp#.WYxWN1GGNPZ, Diabetes UK (riskscore.diabetes.org.uk/start) and the
American Diabetes Association (www.diabetes.org/are-you-at-risk/diabetes-risk-test/ both
have tools that allow visitors to their websites to calculate their individual risk of developing diabetes.
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Figures and Tables
Figure 1: Timing of UKHLS data collection
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Figure 2: Prevalence of hypertension and knowledge gap at baseline
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Figure 3: The effect of survey feedback on reported hypertension
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Figure 4: First stage estimates of the hypertension diagnosis on self-reported hypertension
and other conditions
Figure 5: First stage F-statistics of the hypertension diagnosis on self-reported hyperten-
sion and other conditions
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Figure 6: The impact of hypertension diagnosis on smoking
Note: Each dot is from a separate instrumental variable estimates set out in equation (2). The whiskers
represent the 95% confidence interval calculated from standard errors clustered at the individual level. All
the regressions include individual fixed effects, and the following controls: age, age-squared, age-cubed,
household size, and dummies indicating being married, being employed or self-employed, and having qual-
ifications of A-level or about, plus a set of time dummies. The estimates for pooled also includes separate
trends for those who have i. mildly raised hypertension and ii. raised and considerably raised hypertension.
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Figure 7: The impact of hypertension diagnosis on alcohol expenditure
Note: see note to figure 6
Figure 8: The impact of hypertension diagnosis on self-reported physical health
Note: see note to figure 6
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Figure 9: The impact of hypertension diagnosis on self-reported mental health
Note: see note to figure 6
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Figure 10: The impact of hypertension diagnosis on heart disease related conditions
Note: Each marker is from a separate instrumental variable estimates set out in equation (2). The whiskers
represent the 95% confidence interval calculated from standard errors clustered at the individual level. All
are estimated based on the “pooled” sample (i.e. the sample that goes up to and includes 54 months after
the feedback) that have separate trends for those who have i. mildly raised hypertension and ii. raised and
considerably raised hypertension.
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Figure 11: The impact of hypertension diagnosis on health behaviours
Note: Each dot is from a separate regression (FE-IV) set out in equation (2). The whiskers represent the
95% confidence interval calculated from standard errors clustered at the individual level. Data is from
waves 2 and 5 of the UKHLS. “Bad diet” indicates that an individual either never eats fruit, never eats
vegetables, drinks wholemilk or eats white bread. “Bad lifstyle” indicates whether an individual either
smokes or drinks alcohol 5 or more days a week. Sedentary indicates whether someone has not walked for
more than 10 minutes over the last 4 weeks or they play no sport at all. “All” is a combination of all of
these.
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Figure 12: The impact of hypertension diagnosis on smoking - alternative specifications
Note: Each dot is from a separate regression (FE-IV) set out in equation (2). The whiskers represent the
95% confidence interval calculated from standard errors clustered at the individual level. The top panel
shows the immediate impact, the middle panel shows the long run impact not including trends, and the
bottom panel is also for the long run and does include separate trends for those who have i. mildly raised
hypertension and ii. raised and considerably raised hypertension.39
Table 1: Demographic profile by whether hypertensive
Normotensive Hypertensive Mean Diff SE
Male 0.41 0.48 0.07*** 0.01
Age 45.77 61.45 15.67*** 0.24
Total household net income 2940.68 2396.95 -543.73*** 75.13
Ethnicity:
White 0.93 0.96 0.02*** 0.00
Mixed 0.01 0.01 -0.00* 0.00
Indian and chinese 0.02 0.01 -0.01*** 0.00
Other asian 0.02 0.01 -0.01*** 0.00
African or black caribean 0.01 0.01 0.00 0.00
Other 0.01 0.00 -0.00** 0.00
Highest qualification:
Degree 0.25 0.16 -0.10*** 0.01
Other higher degree 0.13 0.12 -0.01 0.01
A-level 0.21 0.17 -0.04*** 0.01
GCSE 0.22 0.18 -0.04*** 0.01
Other 0.09 0.14 0.05*** 0.00
No qualification 0.10 0.24 0.14*** 0.01
N 12104 6743
Notes: Unweighted sample
Table 2: Demographic profile of hypertensive by knowledge status
Know -ve shock Mean Diff SE
Male 0.45 0.55 0.10*** 0.01
Age 62.78 57.86 -4.92*** 0.40
Total household net income 2283.79 2701.44 417.65** 130.55
Ethnicity:
White 0.96 0.95 -0.01 0.01
Mixed 0.01 0.01 0.00 0.00
Indian and chinese 0.01 0.01 0.00 0.00
Other asian 0.01 0.01 0.00 0.00
African or black caribean 0.01 0.02 0.01 0.00
Other 0.00 0.00 -0.00 0.00
Highest qualification:
Degree 0.14 0.19 0.05*** 0.01
Other higher degree 0.12 0.14 0.02* 0.01
A-level 0.16 0.17 0.01 0.01
GCSE 0.17 0.19 0.02 0.01
Other 0.15 0.13 -0.01 0.01
No qualification 0.26 0.18 -0.08*** 0.01
N 4916 1827
Notes: Unweighted sample
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Table 3: Pre-feedback (mean) gaps by knowledge status and conditional on observables
(1) (2) (3) (4) (5)
Constant HT -ve shock (3)=(2) N
(non-HT) and knew p-value
A. Annual measures
Currently smokes 0.251*** -0.008 0.013 0.041 18508
(15.67) (-1.14) (1.33)
Monthly alcohol spending 61.369*** 2.673 6.478** 0.070 18503
(18.08) (1.92) (3.13)
SF-12 Physical 50.429*** -2.066*** -0.543* 0.000 16123
(144.28) (-12.46) (-2.54)
SF-12 Mental 50.925*** -0.809*** -0.029 0.004 16123
(127.23) (-4.32) (-0.12)
B. Blood pressure
Systolic 120.311*** 10.944*** 28.178*** 0.000 18698
(223.67) (39.59) (96.83)
Diastolic 69.062*** 5.912*** 15.425*** 0.000 18698
(175.69) (30.35) (60.98)
C. Other behaviours
Fruit and vegetable consumption:
Consumes less than WHO guidelines 0.737*** 0.007 0.014 0.513 18491
(47.27) (0.80) (1.31)
# fruit and veg per day 3.521*** -0.021 -0.048 0.528 18491
(60.07) (-0.69) (-1.20)
Diet:
Bad diet (indicator) 0.090*** -0.017*** 0.014 0.000 18506
(8.23) (-3.67) (1.95)
Bad diet (intensity) 0.482*** -0.009 0.050** 0.000 18506
(19.46) (-0.85) (3.13)
Sedentary lifestyle:
Sedentary (indicator) 0.060*** 0.010 0.002 0.275 18498
(6.20) (1.87) (0.24)
Sedentary (intensity) 7.441*** 0.445*** 0.338*** 0.135 18499
(0-10 scale 0=very active, 10=inactive) (77.76) (9.12) (4.94)
Notes: Panel A. lists variables recorded annually; panel B. those collected once at the nurse visit and panel C those
recorded on a rotating basis. Estimates are from linear regression models that include a constant (column 1); a dummy for
self-reporting HT or being HT according to the survey nurse (column 2); a dummy for being HT according to the survey
nurse but self-reporting as not HT (column 3) and demographic controls. Controls are: age up to the third power;
education dummies (4); continuous household income; whether children in the household; ethnicity dummies (6); dummies
for long-standing health conditions (12) and region dummies (10). t-statistics in parenthesis.
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Table 4: Hypertension diagnosis effects on health and health behaviours at six month
follow-up
Outcome Mean OLS RF IV First stage N
at-risk F-stat
Smoking 0.30 † -0.00224 -0.00547** -0.101** 124.3 57,053
(0.00442) (0.00245) (0.0460)
Alcohol Consumption (£per month) 50.68 ‡ 1.452 1.159 21.08 143.1 67,397
(2.062) (1.283) (23.40)
SF-12 Physical 49 .22‡ -0.905*** -0.366** -6.636** 128.4 61,373
(0.313) (0.161) (2.953)
SF-12 Mental 49.99‡ -0.0807 0.169 3.068 128.4 61,373
(0.377) (0.170) (3.096)
CVD 0.28λ 0.0373*** 0.00177 0.0305 116 55,154
(0.00838) (0.00253) (0.0437)
Congestive heart failure 0.02λ 0.00448 -0.00213*** -0.0368*** 116 55,154
(0.00303) (0.000567) (0.0104)
Coronary heart disease 0.09λ 0.00911** -0.00204* -0.0352* 116 55,154
(0.00431) (0.00110) (0.0193)
Angina 0.12λ 0.0148*** 0.000144 0.00248 116 55,154
(0.00538) (0.00149) (0.0257)
Heart Attack 0.12λ 0.00781* 0.000658 0.0113 116 55,154
(0.00436) (0.00172) (0.0297)
Stroke 0.07λ 0.00825* 0.000938 0.0162 116 55,154
(0.00435) (0.00162) (0.0279)
Note: These estimates are based on models that use data from the UKHLS up to and including the wave
after the nurse visit took place. All the models include individual fixed effects. The column labeled OLS
presents the ordinary least squares estimates. The OLS models regress the outcome on the self-reported
hypertension diagnosis. The column labeled “RF” presents reduced-form estimates of the outcome on the
instrument (the nurse diagnosing hypertension interacted with a post-nurse visit dummy). All models include
the following controls: age, age-squared, age-cubed, household size, and dummies indicating being married,
being employed or self-employed, and having qualifications of A-level or about, plus a set of time dummies.
Standard errors are clustered at the individual level. *, ** and *** respectively denote significance at the
10, 5 or 1 percent level.
† at-risk is those with no qualifications and not self-reporting hypertensive.
‡ at-risk is full population.
λ at-risk is males aged over 65.
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Table 5: Hypertension diagnosis effects on health and health behaviours by gender
Male Female
Immediate Pooled Pooled Immediate Pooled Pooled
Outcome w/o trend w trend w/o trend w trend
Smoking -0.155** -0.187*** -0.108 -0.0198 -0.145* -0.0602
(0.0612) (0.0725) (0.0845) (0.0715) (0.0878) (0.128)
N 24,593 38,795 31,885 32,460 51,339 41,738
First stage F-stat 78.62 79.06 71.99 45.75 48.98 32.56
Alcohol Consumption (£) 36.25 32.76 75.18 2.415 27.99 14.20
(31.28) (29.28) (55.51) (36.14) (24.97) (42.47)
N 29,138 59,558 48,672 38,259 78,360 63,493
First stage F-stat 85.07 88.98 90.92 57.20 60.66 61.51
SF-12 Physical -6.848* -6.034** -3.802 -7.496 -4.651 -6.116
(3.557) (2.740) (4.169) (5.139) (4.023) (5.824)
N 26,599 55,510 45,508 34,774 73,194 59,608
First stage F-stat 77.20 86.68 84.17 50.85 58.77 59.70
SF-12 Mental 1.991 3.447 -0.0822 4.337 -1.958 6.419
(3.623) (2.785) (4.282) (5.494) (4.085) (6.431)
N 26,599 55,510 45,508 34,774 73,194 59,608
First stage F-stat 77.20 86.68 84.17 50.85 58.77 59.70
CVD -0.00694 0.129* -0.149* 0.0740 0.194** -0.0633
(0.0528) (0.0738) (0.0773) (0.0761) (0.0968) (0.103)
N 23,753 47,557 36,652 31,401 63,436 48,464
Congestive heart failure -0.0271** -0.0211 -0.0347 -0.0544*** -0.0128 -0.0848**
(0.0123) (0.0231) (0.0231) (0.0188) (0.0307) (0.0370)
N 23,753 47,557 36,652 31,401 63,436 48,464
Coronary heart disease -0.0463** -0.0804** -0.100** -0.0252 0.0186 -0.0762
(0.0227) (0.0367) (0.0438) (0.0348) (0.0497) (0.0522)
N 23,753 47,557 36,652 31,401 63,436 48,464
Angina -0.00536 -0.0174 -0.0160 0.00687 0.0577 0.00750
(0.0342) (0.0423) (0.0430) (0.0399) (0.0511) (0.0532)
N 23,753 47,557 36,652 31,401 63,436 48,464
Heart Attack 0.0646 0.0960* 0.0382 -0.0720** -0.0607 -0.0604
(0.0462) (0.0548) (0.0584) (0.0346) (0.0442) (0.0471)
N 23,753 47,557 36,652 31,401 63,436 48,464
Stroke -0.0287 0.0971** -0.0995** 0.0820 0.110* 0.0291
(0.0291) (0.0461) (0.0461) (0.0556) (0.0649) (0.0653)
N 23,753 47,557 36,652 31,401 63,436 48,464
First stage F-stat 70.09 72.39 72.69 45.37 49.03 48.65
Note: All these estimates are from fixed-effect instrumental variable models. The column “Immediate”
presents estimates based on models that use data from the UKHLS up to and including the wave after
the nurse visit took place. The columns “Pooled w/o trend” and “Pooled w trend” both use data from the
UKHLS up to and including five waves after the nurse visit took place. The trends include are for two groups
i) mildly raised and ii) raised & considerably raised. All models include the following controls: age, age-
squared, age-cubed, household size, and dummies indicating being married, being employed or self-employed,
and having qualifications of A-level or about, plus a set of time dummies. Standard errors are clustered at
the individual level. *, ** and *** respectively denote significance at the 10, 5 or 1 percent level. CVD,
congestive heart failure, coronary heart disease, angina, heart attack and stroke are all based on the same
sample and share the same first stage results reported under stroke.
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Table 6: Hypertension diagnosis effects on health and health behaviours by qualification
level
A-level & above Below A-level
Immediate Pooled Pooled Immediate Pooled Pooled
Outcome w/o trend w trend w/o trend w trend
Smoking -0.105 -0.197** -0.0815 -0.101 -0.146** -0.0914
(0.0682) (0.0853) (0.114) (0.0622) (0.0729) (0.0888)
N 31,427 50,248 40,602 25,331 39,659 32,841
First stage F-stat 58.33 58.89 45.42 66.61 68.69 58.09
Alcohol Consumption (£) 7.831 64.34* 88.28 30.08 3.319 11.83
(35.46) (36.82) (69.03) (30.99) (21.52) (38.52)
N 36,093 76,409 61,629 30,912 61,203 50,290
First stage F-stat 64.72 68.28 67.73 79.54 80.56 83.09
SF-12 Physical -12.35*** -6.587* -13.27** -2.081 -3.403 3.244
(4.482) (3.460) (5.342) (4.012) (3.118) (4.753)
N 33,810 72,981 59,062 27,132 55,389 45,783
First stage F-stat 61.50 64.88 64.03 67.55 79.64 77.90
SF-12 Mental 7.317* 6.573* 9.418* -1.185 -3.445 -5.278
(4.417) (3.487) (5.312) (4.409) (3.280) (5.324)
N 33,810 72,981 59,062 27,132 55,389 45,783
First stage F-stat 61.50 64.88 64.03 67.55 79.64 77.90
CVD 0.0667 0.213** -0.0583 0.00246 0.130 -0.165*
(0.0611) (0.0844) (0.0882) (0.0614) (0.0831) (0.0887)
N 29,611 61,751 46,904 25,185 48,971 38,006
Congestive heart failure -0.00845 0.0194 -0.0371 -0.0597*** -0.0450* -0.0707**
(0.0135) (0.0313) (0.0268) (0.0158) (0.0234) (0.0300)
N 29,611 61,751 46,904 25,185 48,971 38,006
Coronary heart disease -0.0282 -0.0629* -0.0949** -0.0393 -0.0114 -0.0908*
(0.0225) (0.0342) (0.0472) (0.0297) (0.0460) (0.0484)
N 29,611 61,751 46,904 25,185 48,971 38,006
Angina 0.0363 0.0246 0.00830 -0.0249 0.0121 -0.0241
(0.0363) (0.0439) (0.0480) (0.0358) (0.0473) (0.0473)
N 29,611 61,751 46,904 25,185 48,971 38,006
Heart Attack 0.00880 0.0856 -0.0120 0.0138 -0.000801 0.0111
(0.0380) (0.0544) (0.0604) (0.0437) (0.0495) (0.0522)
N 29,611 61,751 46,904 25,185 48,971 38,006
Stroke 0.0451 0.115** 0.0123 -0.00782 0.0957* -0.102*
(0.0395) (0.0517) (0.0502) (0.0390) (0.0555) (0.0571)
N 29,611 61,751 46,904 25,185 48,971 38,006
First stage F-stat 52.65 53.58 52.87 64.33 66.74 66.73
Note: for estimation details see note to table 5
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Table 7: Hypertension diagnosis effects on health and health behaviours by age
Aged 40 and above Aged 50 and above Aged 60 and above
Immediate Pooled Pooled Immediate Pooled Pooled Immediate Pooled Pooled
Outcome w/o trend w trend w/o trend w trend w/o trend w trend
Smoking -0.122** -0.160*** -0.104 -0.157** -0.177** -0.130 -0.215** -0.235** -0.190
(0.0485) (0.0559) (0.0739) (0.0624) (0.0704) (0.0930) (0.0875) (0.0990) (0.119)
N 41,423 67,228 55,442 29,779 49,049 40,627 19,133 32,056 26,837
First stage F-stat 111.8 113.2 87.77 72.45 72.26 59.24 40.82 39.63 36.36
Alcohol Consumption (£) 26.43 31.67 51.78 26.32 40.53 67.32 50.04 80.70** 119.2
(24.44) (21.10) (40.79) (29.74) (27.18) (54.05) (39.01) (38.63) (76.32)
N 48,106 104,274 85,861 34,660 77,098 63,762 22,705 51,377 42,944
First stage F-stat 130.2 131.9 129.1 87.73 86.48 84.50 51.42 49.46 47.98
SF-12 Physical -5.764* -3.264 -3.623 -6.862* -5.382 -5.041 -6.327 -3.020 -2.808
(3.108) (2.447) (3.761) (4.088) (3.290) (4.999) (5.468) (4.509) (6.772)
N 43,358 96,816 80,029 30,873 70,968 58,946 19,744 46,419 38,993
First stage F-stat 114.8 127.5 121 75.97 82.21 77.73 45.46 47.71 44.73
SF-12 Mental 0.575 -0.571 -3.030 1.123 1.454 -2.293 5.258 1.769 -2.544
(3.235) (2.482) (3.998) (4.170) (3.205) (5.269) (5.460) (4.233) (6.911)
N 43,358 96,816 80,029 30,873 70,968 58,946 19,744 46,419 38,993
First stage F-stat 114.8 127.5 121 75.97 82.21 77.73 45.46 47.71 44.73
CVD 0.0364 0.180*** -0.126* 0.0297 0.214** -0.172* 0.0541 0.281** -0.224
(0.0478) (0.0654) (0.0697) (0.0664) (0.0920) (0.0988) (0.0990) (0.141) (0.151)
N 39,202 83,637 65,127 28,289 61,947 48,538 18,407 41,111 32,650
First stage F-stat 106.3 107.6 103.5 69.82 68.67 66.34 40.90 38.34 36.87
Congestive heart failure -0.0400*** -0.0170 -0.0636*** -0.0575*** -0.0397 -0.0817** -0.0923*** -0.0837** -0.125**
(0.0116) (0.0210) (0.0229) (0.0176) (0.0284) (0.0332) (0.0279) (0.0427) (0.0546)
N 39,202 83,637 65,127 28,289 61,947 48,538 18,407 41,111 32,650
Coronary heart disease -0.0370* -0.0365 -0.106*** -0.0462 -0.0400 -0.136** -0.0847* -0.109 -0.196**
(0.0214) (0.0328) (0.0382) (0.0315) (0.0482) (0.0561) (0.0462) (0.0728) (0.0864)
N 39,202 83,637 65,127 28,289 61,947 48,538 18,407 41,111 32,650
Angina 0.00265 0.0113 -0.0154 0.0122 0.0154 -0.00120 0.0384 0.0403 -0.00596
(0.0280) (0.0352) (0.0377) (0.0406) (0.0504) (0.0540) (0.0627) (0.0789) (0.0832)
N 39,202 83,637 65,127 28,289 61,947 48,538 18,407 41,111 32,650
Heart Attack 0.0135 0.0431 -0.00223 0.0127 0.0479 -0.00989 -0.0139 0.0477 -0.0267
(0.0324) (0.0403) (0.0441) (0.0448) (0.0571) (0.0617) (0.0651) (0.0872) (0.0939)
N 39,202 83,637 65,127 28,289 61,947 48,538 18,407 41,111 32,650
Stroke 0.0211 0.117*** -0.0442 0.0128 0.147** -0.0713 -0.000181 0.185** -0.148
(0.0305) (0.0425) (0.0419) (0.0416) (0.0601) (0.0587) (0.0601) (0.0905) (0.0923)
N 39,202 83,637 65,127 28,289 61,947 48,538 18,407 41,111 32,650
First stage F-stat 106.3 107.6 103.5 69.82 68.67 66.34 40.90 38.34 36.87
Note: for estimation details see note to table 5
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Appendix A: Survey vs. clinical measures of blood
pressure
BP would ideally be measured under controlled conditions to remove the influence of
environmental factors that affect it and that make comparisons across different individuals
in the population more complicated. Environmental factors that affect BP are: the time
of day, room temperature, behaviours around the time of measurement, presence of a
medical practitioner (white coat effects) and random fluctuations. If the extent of the
factors varies between the survey interview and the clinic then, for the same sample of
individuals, measured BP will differ across the settings.
While both are objective measures of BP, compared to a clinical measure, the one
from the survey could on average either over–estimate or under–estimate BP. Whether
the issue is of an important magnitude, say when estimating the presence of undiagnosed
HT in the population, is an empirical question. In principle, estimated HT prevalence
could be sensitive to small deviations in BP related to the environmental setting of the
measurement. This occurs because HT is a discontinuous function of BP and therefore HT
status may be sensitive to small perturbations in BP. While the environmental factors
affecting BP have been documented in the medical literature, the impact of them on
estimates of HT prevalence is typically not discussed in the social science literature.
More importantly for the present paper, the measurement issues could result in mis-
classification (eg. being classified as high in the survey when BP would be normal under
the conditions in a clinic) even if on average measured BP was the same in both settings.
This is very relevant for the interpretation of the results in the paper (and in particular
the interpretation of our first stage IV estimates), as it relates to the share of respondents
who should not show a response to a ‘high’ survey feedback in formal diagnoses of HT.
In other words, a proportion measured high in the survey HT will turn out not to be HT
when measured by their GP.
Contrasting to the systematic determinants of BP is random noise that occurs from
reading–to–reading. The same individual measured twice under control conditions, is
1
likely to receive two differing measurements. For this reason, usual practice is to average
over multiple measurements at a given visit, as is done in both the household survey and
in the clinic. Still, averaging over a small number of readings will reduce, but not remove
noise. As above, random noise becomes very important for marginal cases near to the HT
cutt-off ie. a person measured as 139 and normal could ‘become’ high under a different
reading if just a small pertubation raised their BP to 140. While random noise is not
expected to lead to differences in average BP as measured in the survey interview and
clinic, it could lead to misclassification (say where a respondent was measured as 140 and
high in the survey but then found to be 139 and so normal by their GP).
This appendix describes the environmental factors that lead to systematic differences
between BP measured in the survey interview and the clinic. It presents results from
adjusting the survey measures in an attempt to replicate measurements that would be
obtained in the clinical setting such as a GP’s office. The estimates give us an indication
of the extent to which survey respondents who were promopted to visit their GP would
turn out to be HT according to their GP. We find that on average, the survey slightly
over-estimates BP levels compared to ones taken in a GP’s office, but it more seriously
overestimates the share of people classified as being high. Applying our adjustments to the
raw survey measures indicates that 16.7 percent of participants have high BP compared
to 17.7 percent in the unadjusted data. Our adjustments imply misclassification where
8.4 percent of the survey high have normal BP in the adjusted data. We further simulate
additional BP readings by introducing small amounts of random noise to the survey
measures and find that this further increases misclassification.
Below we discuss each of the environmental factors that affects BP and discuss the
effects of our adjustments for each of them:
i) Diurnal variation: BP varies over the day or diurnally. BP is usually highest in
the early morning and evening, and falls in the early afternoon with the lowest readings
being during the night (Kawano (2011)). Survey nurse visits occur across the day but
there is a spike in visits mid-morning and early evening (figure A1). The latter spike
is concurrent with the known evening peak in BP. Approximately 50 percent of nurse
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visits occurred after 15:00 and 25 percent after 18:00 with 99 percent of visits starting
before 8pm (figure A2). As the use of GP services is expected to be spread uniformally
throughout the working day14, measured BP is expected to systematic differ between the
GP and survey setting.
To explore the presence of time of day effects in our data, we estimated a linear re-
gression model for nurse measured blood pressure where we control for time of day up
to the fourth power; room temperature and its square; whether eaten/smoked/drunk
alcohol/done exercise in the 30 minutes prior to the readings (dummy variable) and de-
mographic controls. Figure A3 plots the predicted BP (for a female with a-levels, aged
65, retired and room temperature of 18C). The figure fails to reproduce an early morning
spike in BP, as we have very few early morning observations in our data, however, it does
recreate the other expected patterns. Predicted BP rises steadily from the late afternoon
but with a plateau through the late morning/early afternoon period. Predicted systolic
BP ranges from a minimum of 125.7 at 08:04 and a maximum of 131.0 at 19.23.
Using the regression estimates we adjust each reading to correspond to one taken at
12:00 noon (say in the middle of GP office hours). While the adjustments lead to only
small differences in the mean levels, they lead to larger differences in the shares high and in
misclassification. The mean adjusted systolic (diastolic) is 122.5 (70.9) compared to 123.6
(71.4) in the unadjusted data. Row two of table A1 shows that 15.8 are high according
to adjusted BP but only 17.7 percent are high in the raw measures. Misclassification is
non-trivial with 10.7 percent of individuals originally classified as high being normal once
we adjust for time of day. Conversely, only 0.03 percent of individuals originally classified
as normal are high once we adjust for time of day.
ii) Temperature variation: Blood pressure falls with temperature (Kuneš et al.
(1991)). Temperature differences between a respondents home and the medical setting are
therefore a source of difference between clinical and survey measures of BP.15 In princi-
14In the UK, the most commonly used contract is the General Medical Services contract, which stip-
ulates that ‘core hours’ are 8 am to 6.30 pm and 18% closed at or before 3 pm on at least one weekday
(Public Accounts Committee (2017))
15Related to the above is the seasonal pattern in BP (Woodhouse et al. (1993))
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ple, the survey measures could over estimate (cold home setting) or underestimate (warm
home setting) relative to a GP practice.
Figure A4 confirms BP falls with room temperature in our data, by plotting predicted
BP against temperature from our regression models above. The model predicts that re-
ducing room temperature from 18 degrees to 17 degrees would increase systolic (diastolic)
BP by 0.46 (0.39) points.
We use our regression coefficients to adjust the survey measures to a common tem-
perature (say the temperature in a GP’s practise). Our estimates imply a temperature
threshold of 19.7 degrees below which the unadjusted high prevalence is below the ad-
justed high prevalence and above which the pattern reverses. We first estimate a lower
bound for the maximum underestimation of the survey by assuming a lower bound for the
room temperature expected in the clinical setting. We set the lower bound to 18 degrees–
UK medical guidelines for minimum home room temperature.16 Row three of table A1
shows the results from applying the adjustment. 19 percent of respondents are high once
the adjustment is applied.17 Our upper-bound for the average underestimation of the
survey is therefore 1.3 percentage points. Moreover, 1.5 percent of those normal in the
unadjusted data turn out to be high when we adjust to 18 degrees, whereas 1.9 percent
of those normal in the unadjusted measures are high once the adjustment is applied.
A more plausible room temperature for the clinical setting is 20 degrees – the minimum
recommended by the WHO for the sick, disabled, very old or very young. Row four of the
table shows that when we adjust to 20 degrees 17.5 percent are high, very similar to the
unadjusted value. However, misclassification remains fairly common with 4.88 percent of
the unadjusted high being normal.
iii) Behaviours before the measurement: Behaviours in the period directly pre-
ceding a measurement can also influence the reading. These include: eating; smoking;
drinking alcohol or vigorous exercise. All of these raise blood pressure for a temporary
16NHS choices website (www.nhs.uk/Livewell/winterhealth/Pages/KeepWarmKeepWell.aspx). Ac-
cessed 24/5/17.
1713.1 percent of the sample have a room temperature that is measured by the nurse as below 18
degrees. It is expected that their BP would be overestimated relative to the GP setting. Respondents
with room temperature measured above 18 degrees would be overestimated, relative to the GP setting.
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period. 16.7 percent of our sample mentioned that they had participated in one of the
behaviours in the 30 minutes prior to the survey measurement. We find that as a matter
of practise, these effects turnout to be rather unimportant. Our regression estimates show
the effect of doing one of these is to increase systolic (diastolic) BP by 0.26 (0.68).
It is hard to quantify how common the behaviours are before a GP visit but it seems
plausible that they are more common in the survey setting where respondents were not
instructed to avoid these activities and therefore the survey would tend to overestimate
BP relative to a GP. To estimate an upper bound for the difference between the survey
measures and clinical measures, we assume none who did the activity in the survey would
do it in the GP setting and adjust the survey measures using the coefficients from our
regression model. The share calculated as high is unchanged when the adjustments are
implemented and there is no misclassification (row five of table A1).
iv) White coat hypertension: It is usually thought that BP is higher when measured
in a medical compared to home setting due to nervousness in the presence of medical
experts that may raise BP (white coat effect). (CITE) estimate the size of the effect. In
the case of our survey measure of BP, measurement occurs in the home but in the presence
of a health care specialist (survey nurse). Therefore, it is not clear that BP should be any
lower in the survey setting. Quantifying white coat effects is an interesting challenge for
future research but it is outside the scope of our research design.
v) Combined effect of all adjustments: Table A1 shows the results from applying
all of the adjustments.18 We estimate 16.7 percent are high which is one percentage point
below the unadjusted figure. 91.6 percent of those measured high by the survey nurse are
high according to the adjusted measure. Conversely, 0.6 percent of the normal according
to the survey nurse are high on the adjusted measure.
vi) Random fluctuations in BP: Aside from the systematic factors affecting BP,
there is random variation meaning it varies from reading-to-reading within an individual.
For this reason, usual practise is to average blood pressure over multiple readings at a
18We adjust to the WHO minimum room temperature for the elderly.
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given visit, as is done in the survey.19 Still, it is possible that a survey respondent gets
a different BP reading from their GP than in the survey interview, purely for the reason
that there is noise in any single or group of BP measures.
We simulate for each individual, two additional BP readings and apply the feedback
rules of the survey nurse. The simulated feedback can be thought of as what a respondent
might get at a GP’s office hours, ceteris paribus. The simulations proceed as follows: For
each individual, we estimate ‘true’ BP (separately for systolic and diastolic) by taking the
mean of the three BP scores observed by the survey nurse. We then draw error terms and
add these to the ‘true’ value to give us simulated BP readings measured with error. The
simulated error terms are drawn from a normal distribution with mean and variance set
equal to that in the observed data (that is the distribution of true’ BP minus the observed
BP). We allow the simulated error terms to be drawn from distributions that are reading
specific to allow for the fact that BP systematically falls across readings.
Table A2 shows the results of the simulation. The overall share of those measured high
is hardly changed (17.9 percent) but misclassification is prevalent. Of those classified as
high by the survey nurse, only 87.1 percent are high according to the simulated new
measures. Conversely, 3.0 percent of those normal according to the survey nurse are high
according to the simulated BP readings.
We also examined the combined effect of our simulations for the non-systematic vari-
ations in BP (noise) and the adjustments for the systematic variations (ie. time, temper-
ature, other behaviours). Overall, we find that the survey overestimates the share high
compared to the clinical setting and that misclassification is large. When applying both
the simulations and adjustments we estimate 17.2 percent are high, 84.6 percent of the
survey high are high and 2.8 percent of the survey normal are high.
19For each individual in our data, we observe 3 BP readings that were taken at one minute intervals.
For example, 24.1 percent of those with mildly raised BP according to reading 2, are normotensive
according to reading 3; and 1.4 percent of those raised on reading number 2 are in fact not hypertensive
according to the third reading. Conversely, 4.6 of those normotensive on the second reading where actually
hypertensive according to the third.
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Figure A1: Time of nurse visit
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Figure A2: CDF of time of nurse visit
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Figure A3: Predicted BP by time of day
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Notes: Fitted values from a regression of systolic (diastolic) BP on sex, age (1 year bands),
highest qualification (6 categories), economic status (7 categories), hours since midnight up to
the fifth power and temperature up to the second power, and a dummy for having 
eaten/smoked/drank/exercised in the 30 minutes before the BP reading.
Fitted values are for a female with a-levels, aged 65, retired and room temperature at 18C.
Blood pressure is calculated as the minimum of the 3 nurse readings.
N=18,847
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Figure A4: Predicted BP by room temperature
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Notes: Fitted values from a regression of systolic (diastolic) BP on sex, age (1 year bands),
highest qualification (6 categories), economic status (7 categories), hours since midnight up to
the fifth power and temperature up to the second power, and a dummy for having
eaten/smoked/drank/exercised in the 30 minutes before the BP reading.
Fitted values are for a female with a-levels, aged 65, retired and bp measured at midday.
Blood pressure is calculated as the minimum of the 3 nurse readings.
N=18,847.
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Table A1: Share HT under different BP adjustments
Adjustment type Full population HypertensiveU NormotensiveU
None 17.7 100 0
Time of day (12 noon) 15.8 89.3 0
Temperature (18 degrees) 19 98.5 1.9
Temperature (20 degrees) 17.5 95.1 0.8
Eat/drank/smoked/exercised 17.7 100 0
All adjustments* 16.7 91.6 0.6
Notes: U superscript indicates the unadjusted data. *Temperature is adjusted to 30
degrees.
Table A2: Share HT when introducing random noise to BP
Adjustment type Full population HypertensiveU NormotensiveU
Unadjusted 17.7 100 0
Simulated + unadjusted 17.9 87.1 0.03
Simulated + adjusted 17.2 84.6 2.8
Notes: U superscript indicates the unadjusted data.
*adjustments are for the items in table X.
Appendix B: Additional figures and tables
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Figure B1: Months between second interview and nurse visit
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Figure B2: Sample measurement record card and oral feedback
 
Normal: ‘Your blood pressure is normal.’
2
Mildly raised: ‘Your blood pressure is a bit high today. Blood pressure can vary from
day to day and throughout the day so that one high reading does not necessarily mean
that you suffer from high blood pressure. ’You are advised to visit your GP within 2
months to have a further blood pressure reading to see whether this is a one-off finding
or not.’
Raised: ‘Your blood pressure is a bit high today. Blood pressure can vary from day
to day and throughout the day so that one high reading does not necessarily mean that
you suffer from high blood pressure. You are advised to visit your GP within 2 weeks to
have a further blood pressure reading to see whether this is a one-off finding or not.’
Considerably raised: ‘Your blood pressure is high today. Blood pressure can vary
from day to day and throughout the day so that one high reading does not necessarily
mean that you suffer from high blood pressure. You are strongly advised to visit your
GP within 5 days to have a further blood pressure reading to see whether this is a one-off
finding or not.’
3
Table B1: Summary Statistics by Consent Status
Non-consenters Consenters Mean Diff SE
Male 0.4455 0.4410 -0.0045 0.0053
Age 46.0141 50.2850 4.2709*** 0.1959
Highest qualification:
Degree 0.1933 0.2164 0.0231*** 0.0044
Other higher degree 0.1048 0.1239 0.0191*** 0.0034
A-level 0.2175 0.1948 -0.0227*** 0.0043
GCSE 0.2245 0.2094 -0.0150*** 0.0044
Other 0.1014 0.1107 0.0093** 0.0033
No qualification 0.1585 0.1448 -0.0137*** 0.0039
General health:
Excellent 0.1653 0.1535 -0.0118** 0.0039
Very good 0.3379 0.3435 0.0056 0.0051
Good 0.2843 0.2820 -0.0023 0.0048
Fair 0.1476 0.1563 0.0087* 0.0039
Poor 0.0649 0.0647 -0.0002 0.0026
Hypertension (self-reported) 0.2415 0.2608 0.0193*** 0.0049
Economic status:
Self-employed 0.0724 0.0717 -0.0007 0.0028
Employed 0.4812 0.4634 -0.0177*** 0.0054
Unemployed 0.0571 0.0422 -0.0148*** 0.0023
Retired 0.2136 0.2748 0.0612*** 0.0046
Student 0.0717 0.0473 -0.0244*** 0.0025
Long-term sick or disabled 0.0343 0.0362 0.0019 0.0020
Other 0.0697 0.0643 -0.0054* 0.0027
Gross household income (monthly) 3571.57 3540.06 -31.51 50.019
N 15,267 20,234
Note: Non-consenters consist of those refusing a nurse visit (N=14,817) or consenting but not
providing 3 valid blood pressure readings (N=450).
Table B2: Feedback thresholds based on the minimum of the second two nurse readings
Classification Systolic Diastolic
Normal ≤ 140 and ≤ 90
Mildly raised 140-159 or 90-99
Raised 160-179 or 110-114
Considerably raised 180≥ or 115≥
4
Figure B3: The impact of hypertension diagnosis on alcohol spending - alternative speci-
fications
Note: Each dot is from a separate regression (FE-IV) set out in equation (2). The whiskers represent the
95% confidence interval calculated from standard errors clustered at the individual level. The top panel
shows the immediate impact, the middle panel shows the long run impact not including trends, and the
bottom panel is also for the long run and does include separate trends for those who have i. mildly raised
hypertension and ii. raised and considerably raised hypertension.
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Figure B4: The impact of hypertension diagnosis on SF-12 Physical - alternative specifi-
cations
Note: Each dot is from a separate regression (FE-IV) set out in equation (2). The whiskers represent the
95% confidence interval calculated from standard errors clustered at the individual level. The top panel
shows the immediate impact, the middle panel shows the long run impact not including trends, and the
bottom panel is also for the long run and does include separate trends for those who have i. mildly raised
hypertension and ii. raised and considerably raised hypertension.
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Figure B5: The impact of hypertension diagnosis on SF-12 Physical - alternative specifi-
cations
Note: Each dot is from a separate regression (FE-IV) set out in equation (2). The whiskers represent the
95% confidence interval calculated from standard errors clustered at the individual level. The top panel
shows the immediate impact, the middle panel shows the long run impact not including trends, and the
bottom panel is also for the long run and does include separate trends for those who have i. mildly raised
hypertension and ii. raised and considerably raised hypertension.
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Figure B6: The impact of hypertension diagnosis on CVD - alternative specifications
Note: Each dot is from a separate regression (FE-IV) set out in equation (2). The whiskers represent the
95% confidence interval calculated from standard errors clustered at the individual level. The top panel
shows the shows the long run impact not including trends, and the bottom panel is for the long run and does
include separate trends for those who have i. mildly raised hypertension and ii. raised and considerably
raised hypertension.
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Figure B7: The impact of hypertension diagnosis on congestive heart failure - alternative
specifications
Note: Each dot is from a separate regression (FE-IV) set out in equation (2). The whiskers represent the
95% confidence interval calculated from standard errors clustered at the individual level. The top panel
shows the shows the long run impact not including trends, and the bottom panel is for the long run and does
include separate trends for those who have i. mildly raised hypertension and ii. raised and considerably
raised hypertension.
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Figure B8: The impact of hypertension diagnosis on coronary heart disease - alternative
specifications
Note: Each dot is from a separate regression (FE-IV) set out in equation (2). The whiskers represent the
95% confidence interval calculated from standard errors clustered at the individual level. The top panel
shows the shows the long run impact not including trends, and the bottom panel is for the long run and does
include separate trends for those who have i. mildly raised hypertension and ii. raised and considerably
raised hypertension.
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Figure B9: The impact of hypertension diagnosis on angina - alternative specifications
Note: Each dot is from a separate regression (FE-IV) set out in equation (2). The whiskers represent the
95% confidence interval calculated from standard errors clustered at the individual level. The top panel
shows the shows the long run impact not including trends, and the bottom panel is for the long run and does
include separate trends for those who have i. mildly raised hypertension and ii. raised and considerably
raised hypertension.
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Figure B10: The impact of hypertension diagnosis on heart attacks - alternative specifi-
cations
Note: Each dot is from a separate regression (FE-IV) set out in equation (2). The whiskers represent the
95% confidence interval calculated from standard errors clustered at the individual level. The top panel
shows the shows the long run impact not including trends, and the bottom panel is for the long run and does
include separate trends for those who have i. mildly raised hypertension and ii. raised and considerably
raised hypertension.
12
Figure B11: The impact of hypertension diagnosis on stokes - alternative specifications
Note: Each dot is from a separate regression (FE-IV) set out in equation (2). The whiskers represent the
95% confidence interval calculated from standard errors clustered at the individual level. The top panel
shows the shows the long run impact not including trends, and the bottom panel is for the long run and does
include separate trends for those who have i. mildly raised hypertension and ii. raised and considerably
raised hypertension.
13
Appendix C: Data Appendix
Self-reported GP diagnosis:
On entering the panel: Has a doctor or other health professional ever told you that you
have any of the conditions listed on this card? Please just tell me the numbers that apply
(see below).
At a second and subsequent interviews: Since [date of last interview] has a doctor or other
health professional newly diagnosed you as having any of the conditions listed on this
card? If so, which ones?
1. Asthma
2. Arthritis
3. Congestive heart failure
4. Coronary heart disease
5. Angina
6. Heart attack or myocardial infarction
7. Stroke
8. Emphysema
9. Hyperthyroidism or an over-active thyroid
10. Hypothyroidism or an under-active thyroid
11. Chronic bronchitis
12. Any kind of liver condition
13. Cancer or malignancy
14. Diabetes
15. Epilepsy
16. High blood pressure
17. Clinical depression
96. None of these
Timing of UKHLS data collection:
Table C1 shows the timing of data collection. Questions on household composition, happi-
1
Table C1: UKHLS content and timing of collection
Wave Module tUKHLS tBHPS
All household composition, general health, phys-
ical and mental health, health conditions
including hypertension, hospitalisations, life
satisfaction, employment, income and spend-
ing
All All
2+ retirement planning t=0 t=-1
2 and 5 Lifestyle: diet, exercise, alcohol consumption
and smoking
t=0 and t=3 t=-1 and t=2
ness, general health, physical and mental health, health conditions including hypertension,
hospitalisations, life satisfaction, employment, income and spending are asked directly at
every wave. Information on retirement planning is asked at every wave from wave 2
onwards and savings data is collected in every other wave starting at wave 2. Lifestyle
questions form part of rotating modules (waves 2 and wave 5) and include details of
diet, exercise, alcohol consumption and smoking behaviour. Attitudes to risk were also
collected (wave 1).
The lifestyle information usually has a short reference period referring to the month or
week before the interview date, with some minor exceptions. For nutrition, information is
collected on the usual number of days per week that fruit and vegetables are each eaten,
and how many portions of each are eaten on a usual day. Alongside this, the main type
of milk that is consumed (whole, semi-skimmed, skimmed, soya, other) and main type of
bread (white, wholemeal, granary etc.) is recorded. For exercise, respondents are asked
whether they have walked continuously for at least 10 minutes and 30 minutes in the past
4 weeks, the number of days for which this occurred and their self-reported average pace
(slow, steady, brisk, fast). The type of any sports activities done are reported for the last
12 months. For alcohol consumption, respondents report whether they drank in the last
week, for how many days, and the quantity on the day they drank the most. Separate
variables also record the frequency of drinking in the past year and household spending
on alcohol in the last 4 weeks. For smoking, we observe whether respondents have ever
smoked, whether they currently smoke, the ages at which they started and gave-up, and
2
the usual quantity of cigarettes smoked per day.
3
